<DOC>
	<DOCNO>NCT02929407</DOCNO>
	<brief_summary>The purpose trial investigate safety , tolerability , pharmacodynamics , pharmacokinetics intravenous administration FE 204205 patient cirrhotic portal hypertension .</brief_summary>
	<brief_title>A Study Investigate Effect Study Drug ( FE 204205 ) Patients With Cirrhotic Portal Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<criteria>1865 year age Verified cirrhotic portal hypertension Coexisting disease e.g . significant organ failure decompensated cirrhosis Type 1 hepatorenal syndrome Acuteonchronic liver failure Hepatic encephalopathy â‰¥grade 2 Hepatocellular carcinoma History underlie chronic heart disease Use vasopressin terlipressin within 7 day prior dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>